Here we report novel mechanism(s) of GATA6 regulation and function in pulmonary vasculature and provide the evidence demonstrating the attractiveness of the GATA6 axis as a molecular target pathway for therapeutic intervention in PAH. Here, GATA6 is linked to pulmonary arterial hypertension.